Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Clinical trial NCT07307235 · RECRUITING
Trial details
- NCT number
- NCT07307235
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-13
- Primary completion
- 2027-06-30
- Enrollment
- 1316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.